1 active not recruiting, 1 not yet recruiting, 1 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Duration of Response: new trials by email Literature Review of Duration of Response trials Research Report on Duration of Response
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma SCA Induction followed by Response-Adapted Therapy - Complete Remission Rateļ¼ CRR, Progression Free Survival | Not applicable | Not yet recruiting | Sun Yat-sen University | 30 | 2026-06-01 | 2026-04-21 |
| Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks Low, non-weight based dose of Dexamethasone and Dexmedetomidine in peripheral nerve blocks, Ropivacaine with low, non weight based Dexamethasone additive - Postoperative Pain, Nausea and Vomiting, Postoperative | Phase 1 / Phase 2 | Active not recruiting | University of Arizona | 100 | 2024-10-10 | 2026-02-13 |
| Real-world Study for Patients With Advanced Hepatobiliary Tumors Precision oncology including targeted therapy and immunotherapy - Objective Response Rate, Progression-free Survival | Unknown | Peking Union Medical College Hospital | 3000 | 2017-07-01 | 2023-03-29 |
Constipation (1) · Dizziness (1) · Lymphoma, Extranodal NK-T-Cell (1) · Pain, Postoperative (1) · Postoperative Nausea and Vomiting (1)
Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell (1) · Nausea (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neurologic Manifestations (1) · Pain (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Postoperative Complications (1) · Sensation Disorders (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1) · Vomiting (1)
Dexamethasone (1) · Dexmedetomidine (1) · Immunotherapy (1) · Ropivacaine (1)
Peking Union Medical College Hospital (1) · Sun Yat-sen University (1) · University of Arizona (1)
China (2) · United States (1)
Haitao Zhao (1) · Ronald Tang, MD (1)
PMID 32832493, PMID 32874058, PMID 33972389, PMID 34430522, PMID 34873013, PMID 35022908, PMID 35464281, PMID 36389129, PMID 36569829, PMID 36733485, PMID 36742297, PMID 36753026, PMID 36970591, PMID 37787790, PMID 38281914